Eric Escobar-Cabrera
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- HER2/EGFR in Cancer Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Lawrence P. McIntosh (5 shared papers)Mark Okon (2 shared papers)Surjit B. Dixit (4 shared papers)Alexander M. Ishov (2 shared papers)Serena Giovinazzi (2 shared papers)Jason Baardsnes (2 shared papers)Paula I. Lario (2 shared papers)Yves Durocher (2 shared papers)
- Journals
- mAbs (3 papers)Biochemistry (2 papers)Journal of Biological Chemistry (1 paper)Nature Communications (1 paper)Structure (1 paper)
- Partner nations
- CanadaUnited StatesNetherlands
In The Last Decade
Eric Escobar-Cabrera
11 papers receiving 377 citations
Peers
Comparison fields: 5 of 39
- Radiology, Nuclear Medicine and Imaging 163
- Oncology 58
- Structural Biology 5
- Molecular Biology 106
- Cell Biology 16
Countries citing papers authored by Eric Escobar-Cabrera
This map shows the geographic impact of Eric Escobar-Cabrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Escobar-Cabrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Escobar-Cabrera more than expected).
Fields of papers citing papers by Eric Escobar-Cabrera
This network shows the impact of papers produced by Eric Escobar-Cabrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Escobar-Cabrera. The network helps show where Eric Escobar-Cabrera may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Escobar-Cabrera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 134 | |
| 2 | 2013 | 110 | |
| 3 | 2011 | 42 | |
| 4 | 2011 | 33 | |
| 5 | 2011 | 29 | |
| 6 | 2010 | 25 | |
| 7 | 2005 | 14 | |
| 8 | 2017 | 9 | |
| 9 | 2023 | 8 | |
| 10 | 2005 | 4 | |
| 11 | 2022 | 3 |
About Eric Escobar-Cabrera
Eric Escobar-Cabrera is a scholar working on Radiology, Nuclear Medicine and Imaging, Catalysis, Molecular Biology, Cell Biology and Infectious Diseases, having authored 11 papers that have together received 411 indexed citations. Recurring topics across this work include Protein Structure and Dynamics (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Lipid Membrane Structure and Behavior (1 paper), Ubiquitin and proteasome pathways (1 paper), Microtubule and mitosis dynamics (1 paper), Bacterial Genetics and Biotechnology (1 paper), HER2/EGFR in Cancer Research (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (163 citations), Oncology (58 citations), Structural Biology (5 citations), Molecular Biology (106 citations) and Cell Biology (16 citations). Eric Escobar-Cabrera has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Lawrence P. McIntosh, Mark Okon, Surjit B. Dixit, Alexander M. Ishov, Serena Giovinazzi, Jason Baardsnes, Paula I. Lario, Yves Durocher, John F. Kelly and Mark Paetzel. Their work appears in journals such as mAbs, Biochemistry, Journal of Biological Chemistry, Nature Communications and Structure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.